Ranbaxy: 'Excessive' Atty Fee Bid In Ranbaxy MDL Slashed By $36M

A Boston federal judge has cut $36 million from an "excessive" fee request by attorneys for two classes of plaintiffs that settled multidistrict antitrust claims against Ranbaxy Pharmaceuticals for $485 million.